Bortezomib (Velcade™) plus Adriamycin™ plus thalidomide plus dexamethasone (VATD) as an effective regimen in patients with refractory or relapsed multiple myeloma (MM)

被引：0
|
作者：
Hollmig, K [1 ]
Stover, J [1 ]
Talamo, G [1 ]
Fassas, A [1 ]
Lee, CK [1 ]
Anaissie, E [1 ]
Tricot, G [1 ]
Barlogie, B [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2399
引用
收藏
页码：659A / 659A
页数：1
相关论文
共 50 条
  • [1] VTD regimen (velcade plus thalidomide plus dexamethasone) - Effective and feasible therapy of refractory/relapsed multiple myeloma
    Gregora, E.
    Pour, L.
    Pavlicek, P.
    Kozak, T.
    Hajek, R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 158 - 158
  • [2] Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Iida, Shinsuke
    Wakabayashi, Masashi
    Tsukasaki, Kunihiro
    Miyamoto, Kenichi
    Maruyama, Dai
    Yamamoto, Kazuhito
    Takatsuka, Yoshifusa
    Kusumoto, Shigeru
    Kuroda, Junya
    Ando, Kiyoshi
    Kikukawa, Yoshitaka
    Masaki, Yasufumi
    Kobayashi, Miki
    Hanamura, Ichiro
    Asai, Hiroaki
    Nagai, Hirokazu
    Shimada, Kazuyuki
    Tsukamoto, Norifumi
    Inoue, Yoshiko
    Tobinai, Kensei
    [J]. CANCER SCIENCE, 2018, 109 (05) : 1552 - 1561
  • [3] Marked activity of velcade plus thalidomide (V plus T) in advanced and refractory multiple myeloma (MM).
    Zangari, M
    Barlogie, B
    Hollmig, K
    Fassas, A
    Rasmussen, E
    Thertulien, R
    Talamo, G
    Lee, CK
    Tricot, G
    [J]. BLOOD, 2004, 104 (11) : 413A - 414A
  • [4] EFFICACY AND SAFETY OF BORTEZOMIB PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Sanchez, R. Garcia
    Saldana, R.
    Caparros, I.
    Gallardo, A.
    Garcia-Delgado, R.
    Rosell, A.
    Campos, A.
    de Llano, M. P. Queipo
    Perez, I.
    Moreno, M. J.
    Del Castillo, S.
    De la Torre, S.
    Ramirez, G.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 500 - 500
  • [5] Bortezomib with Thalidomide plus Dexamethasone Compared with Thalidomide plus Doxorubicin and Dexamethasone as Induction Therapy in Previously Untreated Multiple Myeloma Patients
    Buda, Gabriele
    Orciuolo, Enrico
    Carulli, Giovanni
    Galimberti, Sara
    Ghio, Francesco
    Cervetti, Giulia
    Pelosini, Matteo
    Petrini, Mario
    [J]. ACTA HAEMATOLOGICA, 2013, 129 (01) : 35 - 39
  • [6] Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States
    Jakubowiak, Andrzej J.
    Houisse, Ivan
    Majer, Istvan
    Benedict, Agnes
    Campioni, Marco
    Panjabi, Sumeet
    Ailawadhi, Sikander
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (12) : 1107 - 1119
  • [7] BORTEZOMIB PLUS DEXAMETHASONE IN COMBINATION WITH MELPHALAN OR CYCLOPHOSPHAMIDE IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Tsirigotis, P.
    Girkas, K. G.
    Giannopoulou, V.
    Chondropoulos, S.
    Ioannidou, E.
    Papaxoinis, G.
    Pappa, V.
    Vasilatou, D.
    Dimoula, K.
    Kapodistrias, N.
    Papageorgiou, E.
    Economopoulos, T.
    Dervenoulas, J.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 436 - 436
  • [8] Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
    Bahlis, Nizar J.
    Sutherland, Heather
    White, Darrell
    Sebag, Michael
    Lentzsch, Suzanne
    Kotb, Rami
    Venner, Christopher P.
    Gasparetto, Cristina
    Del Col, Aldo
    Neri, Paola
    Reece, Donna
    Kauffman, Michael
    Shacham, Sharon
    Unger, T. J.
    Jeha, Jacqueline
    Saint-Martin, Jean-Richard
    Shah, Jatin
    Chen, Christine
    [J]. BLOOD, 2018, 132 (24) : 2546 - 2554
  • [9] Low dose velcade, thalidomide and dexamethasone (LD-VTD): An effective regimen for relapsed and refractory multiple myeloma patients
    Ciolli, S
    Leoni, F
    Gigli, F
    Rigacci, L
    Bosi, A
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (01) : 171 - 173
  • [10] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Spencer, Andrew
    Attal, Michael
    Prince, H. Miles
    Harousseau, Jean-Luc
    Dmoszynska, Anna
    San Miguel, Jesus
    Hellmann, Andrzej
    Facon, Thierry
    Foa, Robin
    Corso, Alessandro
    Masliak, Zvenyslava
    Olesnyckyj, Marta
    Yu, Zhinuan
    Patin, John
    Zeldis, Jerome B.
    Knight, Robert D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
12345